Minnesota MMJ Producer Aims to Raise $21M in Funding

Just Released! Get realistic market forecasts, state-by-state insights and benchmarks with the new 2024 MJBiz Factbook member program, now with quarterly updates. Make informed decisions.

LeafLine Labs, one of Minnesota’s two medical cannabis producers and distributors, has begun a new round of fundraising with a goal of reeling in $21 million from investors.

The company already has raised $150,000 toward that end, the Minneapolis/St. Paul Business Journal reported. Last year, it raised nearly $15 million, a sign that investors remain interested in Minnesota’s medical marijuana market despite its slow start.

The state’s other MMJ company, Minnesota Medical Solutions – together with its parent company,  Vireo Health – also is seeking investors. MinnMed, as it’s known, is trying to raise $31.5 million to fund expansion throughout the country.

Although the MMJ industry in Minnesota got off to a rocky start, with only a few hundred patients registering for the program, last year’s addition of intractable pain to the list of qualifying conditions is expected to translate into a customer boom for the two companies – once pain patients are allowed to start signing up in August.